LUTETIUM OXODOTREOTIDE LU-177 for neuroendocrine tumors

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Jul 2021: Trial registered, NCT04954820
  2. 18 Oct 2021: Trial started, NCT04954820

The trials

NCT04954820: Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET

State
Under way
Phase
Phase 2
People
146 planned
Started
18 Oct 2021
Primary completion
Oct 2033
Arms
Experimental arm
Results
None posted
  1. 8 Jul 2021: Trial registered
  2. 18 Oct 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Lutathera.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.